ticagrelor 60 MG Oral Tablet [Brilinta]

RxCUI: 1666334
RxNorm name: ticagrelor 60 MG Oral Tablet [Brilinta]
Display name: ticagrelor 60 MG Oral Tablet [Brilinta]
Full name: ticagrelor 60 MG Oral Tablet [Brilinta]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:28

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
BRILINTA	TICAGRELOR	AstraZeneca Pharmaceuticals LP	f7b3f443-e83d-4bf2-0e96-023448fed9a8	2026-05-07	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1666334

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
f7b3f443-e83d-4bf2-0e96-023448fed9a8	ticagrelor 60 MG Oral Tablet [Brilinta]	SBD	55	These highlights do not include all the information needed to use BRILINTA safely and effectively. See full prescribing information for BRILINTA. BRILINTA® (ticagrelor) tablets, for oral use Initial U.S. Approval: 2011	20260507
f7b3f443-e83d-4bf2-0e96-023448fed9a8	Brilinta 60 MG Oral Tablet	SY	55	These highlights do not include all the information needed to use BRILINTA safely and effectively. See full prescribing information for BRILINTA. BRILINTA® (ticagrelor) tablets, for oral use Initial U.S. Approval: 2011	20260507
f7b3f443-e83d-4bf2-0e96-023448fed9a8	BRILINTA (ticagrelor) 60 MG Oral Tablet	PSN	55	These highlights do not include all the information needed to use BRILINTA safely and effectively. See full prescribing information for BRILINTA. BRILINTA® (ticagrelor) tablets, for oral use Initial U.S. Approval: 2011	20260507